Feature Juniper Pharma’s lidocaine vaginal gel data due in Q3 By Len Zehr Juniper Pharmaceuticals (NASDAQ:JNP) expects to report results in the third quarter from a Phase 2b clinical trial of its 10% lidocaine bioadhesive vaginal gel, COL-1077, a local anesthetic for pain from... June 28, 2016